Clinical Role - Specialty Pharmacy

Pharmacy Times® is a leader in providing expert insights and clinical updates to specialty pharmacists and reaches more than 200,000 pharmacy professionals in total.

Younger Age Groups Experiencing Increase in Obesity-Associated Cancers
Obesity-associated cancer burden is shifting toward younger individuals, with more dramatic increases in some populations than others.
Pembrolizumab/Lenvatinib Combo Tops Week in Review
Top news of the day from across the health care landscape.
Trending News Today: Janssen Submits sBLA for Guselkumab in Psoriatic Arthritis
Top news of the day across the health care landscape.
Transplantation of Hepatitis C-infected Kidneys Found Safe for Non-infected Patients
Transplanting organ from patients infected with hepatitis C could greatly expand the number of kidneys available and reduce wait times.
Novel Hemophilia A Treatment Method Sees Early Success
New approach involves treating patients with a high dose factor VIII concentrates along with emicizumab, a modification of the standard immune tolerance induction.
Trending News Today: Acute Myeloid Leukemia Drug Improves Overall Survival
Top news of the day from across the health care landscape.
Certain BRAF Mutations in Colorectal Cancer May Respond to Anti-EGFR Therapy
Patients with metastatic colorectal cancer harboring certain non-V600 BRAF mutations may benefit from anti-EGFR treatment. 
Lessons Learned: Starting a Health-System, Oncology-focused Specialty Pharmacy
Health-system–owned and operated specialty pharmacies have become a trend to not only capture previously unrealized profit but to also close the gap between provider, patient, and medication.
FDA OKs Pembrolizumab/Lenvatinib Combo for Advanced Endometrial Carcinoma
The FDA approval of pembrolizumab plus lenvatinib for this new indication is the first under a new international collaboration with Australia and Canada.
Ofatumumab Demonstrates Efficacy in Relapsing Multiple Sclerosis
Two phase 3 studies showed that ofatumumab was superior to teriflunomide (Aubagio) in patients with relapsing forms of multiple sclerosis.
New Direction in Chronic Inflammation Treatment Development
Research demonstrates a new direction in cell signaling and treatment for chronic inflammatory diseases such as psoriasis, asthma, and HIV. 
+ Load More